CAS RN: 5654-94-4
Octahydro-1H-pyrrolo[3,4-b]pyridine
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
≥95% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20260222
1g
Out of stock
15 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.25g, 1g
Available purity: >97%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 5654-94-4
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.25g
>97%
0
Out of Stock
Shanghai
Inquiry
1g
>97%
0
Out of Stock
Shanghai
Inquiry
5654-94-4 / 2,3,4,4a,5,6,7,7a-octahydro-1H-pyrrolo[3,4-b]pyridine
Standard CAS: 5654-94-4
Multi CAS: No
Basic Information
copy
CAS
5654-94-4 copy
Multi CAS
No copy
Molecular Formula
C7H14N2 copy
Molecular Weight
126.200000 copy
Exact Mass
126.115698 copy
InChI
InChI=1S/C7H14N2/c1-2-6-4-8-5-7(6)9-3-1/h6-9H,1-5H2 copy
InChIKey
KSCPLKVBWDOSAI-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
9 copy
Fraction Csp3
1 copy
H-bond acceptors
2 copy
H-bond donors
2 copy
Molar refractivity
37.38 copy
TPSA
24.06 copy
LogP / Solubility
WLOGP
-0.04 copy
MLOGP
-0.05 copy
Consensus LogP
-0.03 copy
Log S (ESOL)
-0.6 copy
Class (ESOL)
Very soluble copy
Log S (Ali)
-0.56 copy
Class (Ali)
Very soluble copy
Log S (SILICOS-IT)
-0.45 copy
Class (SILICOS-IT)
Very soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.52 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
2.5 copy